Form4insider filings, from the source

SEC Form 4 · accession 0001209191-17-020164

CONCERT PHARMACEUTICALS, INC. · CNCE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Robert Silverman
Officer — Senior VP, General Counsel
Period of report
Mar 9, 2017
Accepted (ET)
Mar 13, 2017 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001367920

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Mar 9, 2017M19,497$1.13A40,912D
Common StockF1Mar 9, 2017F1,306$16.86D39,606D
Common StockF2Mar 9, 2017M11,469$1.13A51,075D
Common StockF2Mar 9, 2017F768$16.86D50,307D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)F3$1.13Mar 9, 2017M19,497D—Jun 4, 2017Common Stock19,4970D
Employee Stock Option (right to buy)F3$1.13Mar 9, 2017M11,469D—Dec 11, 2017Common Stock11,4690D

Explanation of responses